Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

EpiMII: Structure-Aware Graph Neural Networks for MHC-II Epitope Generation.

Research (Washington, D.C.)·2026
Same author

Impact of antidiabetic therapy on cognitive function in patients with type 2 diabetes and Alzheimer's disease: A comprehensive analysis.

Journal of Alzheimer's disease : JAD·2025
Same author

EpiMII: Integrating Structure and Graph Neural Networks for MHC-II Epitope and Neoantigen Design.

bioRxiv : the preprint server for biology·2025
Same author

ProstaNet: A Novel Geometric Vector Perceptrons-Graph Neural Network Algorithm for Protein Stability Prediction in Single- and Multiple-Point Mutations with Experimental Validation.

Research (Washington, D.C.)·2025
Same author

GCN-BBB: Deep Learning Blood-Brain Barrier (BBB) Permeability PharmacoAnalytics with Graph Convolutional Neural (GCN) Network.

The AAPS journal·2025
Same author

GraphDeep-hERG: Graph Neural Network PharmacoAnalytics for Assessing hERG-Related Cardiotoxicity.

Pharmaceutical research·2025

Related Experiment Video

Updated: Jun 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

Recent advances in fragment-based QSAR and multi-dimensional QSAR methods.

Kyaw Zeyar Myint1, Xiang-Qun Xie

  • 1Department of Computational Biology, School of Medicine, University of Pittsburgh, Pittsburgh, PA 15260, USA;

International Journal of Molecular Sciences
|December 15, 2010
PubMed
Summary
This summary is machine-generated.

This review covers recent 2D fragment-based quantitative structure-activity relationship (QSAR) methods and multi-dimensional QSAR approaches. It highlights key techniques like FS-QSAR, HQSAR, and advanced 3D- and nD-QSAR methods for drug discovery.

Keywords:
2D-QSAR3D-QSARQSARfragment similarity basedfragment-basednD-QSAR

More Related Videos

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Related Experiment Videos

Last Updated: Jun 6, 2026

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode
09:19

NMR-Based Fragment Screening in a Minimum Sample but Maximum Automation Mode

Published on: June 4, 2021

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source
08:35

Achieving Efficient Fragment Screening at XChem Facility at Diamond Light Source

Published on: May 29, 2021

Area of Science:

  • Computational Chemistry
  • Medicinal Chemistry
  • Drug Discovery

Background:

  • Quantitative Structure-Activity Relationship (QSAR) studies are crucial for predicting drug efficacy.
  • Traditional QSAR methods have evolved to incorporate multi-dimensional and fragment-based approaches.
  • There is a growing need for advanced QSAR techniques to improve drug design and development.

Purpose of the Study:

  • To provide a comprehensive overview of recently developed 2D fragment-based QSAR methods.
  • To discuss various multi-dimensional QSAR approaches (3D- and nD-QSAR).
  • To highlight key methodologies and their applications in drug discovery.

Main Methods:

  • Fragment-based QSAR (FB-QSAR) techniques including fragment-similarity-based QSAR (FS-QSAR) and Hologram QSAR (HQSAR).
  • Multi-dimensional QSAR methods such as comparative molecular field analysis (CoMFA) and comparative molecular similarity analysis (CoMSIA).
  • Exploration of advanced 3D- and nD-QSAR techniques like Topomer CoMFA, SOMFA, COMMA, AMSP, WHIM, GRIND, 4D-QSAR, 5D-QSAR, and 6D-QSAR.

Main Results:

  • Recent advancements in 2D fragment-based QSAR offer novel ways to analyze molecular structures.
  • Multi-dimensional QSAR methods provide enhanced capabilities for modeling complex structure-activity relationships.
  • These diverse QSAR approaches collectively contribute to more accurate predictions in drug design.

Conclusions:

  • Fragment-based and multi-dimensional QSAR methods represent significant progress in computational drug discovery.
  • The presented techniques offer powerful tools for understanding and predicting the biological activity of chemical compounds.
  • Continued development and application of these QSAR strategies are essential for future pharmaceutical research.